234 related articles for article (PubMed ID: 19223494)
21. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
[TBL] [Abstract][Full Text] [Related]
22. Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor.
Wang L; Schmitz V; Perez-Mediavilla A; Izal I; Prieto J; Qian C
Mol Ther; 2003 Jul; 8(1):72-9. PubMed ID: 12842430
[TBL] [Abstract][Full Text] [Related]
23. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential.
Barnstable CJ; Tombran-Tink J
Prog Retin Eye Res; 2004 Sep; 23(5):561-77. PubMed ID: 15302351
[TBL] [Abstract][Full Text] [Related]
25. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.
Drevs J; Hofmann I; Hugenschmidt H; Wittig C; Madjar H; Müller M; Wood J; Martiny-Baron G; Unger C; Marmé D
Cancer Res; 2000 Sep; 60(17):4819-24. PubMed ID: 10987292
[TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
27. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of continuously administered PEDF-derived synthetic peptides against osteosarcoma growth and metastasis.
Broadhead ML; Choong PF; Dass CR
J Biomed Biotechnol; 2012; 2012():230298. PubMed ID: 22701300
[TBL] [Abstract][Full Text] [Related]
29. Pigment epithelium-derived factor gene loaded in cRGD-PEG-PEI suppresses colorectal cancer growth by targeting endothelial cells.
Li L; Yang J; Wang WW; Yao YC; Fang SH; Dai ZY; Hong HH; Yang X; Shuai XT; Gao GQ
Int J Pharm; 2012 Nov; 438(1-2):1-10. PubMed ID: 22974524
[TBL] [Abstract][Full Text] [Related]
30. PEDF and 34-mer inhibit angiogenesis in the heart by inducing tip cells apoptosis via up-regulating PPAR-γ to increase surface FasL.
Zhang H; Wei T; Jiang X; Li Z; Cui H; Pan J; Zhuang W; Sun T; Liu Z; Zhang Z; Dong H
Apoptosis; 2016 Jan; 21(1):60-8. PubMed ID: 26519036
[TBL] [Abstract][Full Text] [Related]
31. Pigment epithelium-derived factor inhibits the growth of human esophageal squamous cell carcinoma by suppressing neovascularization.
Kadoya M; Tamoto E; Shichinohe T; Hirano S
Hokkaido Igaku Zasshi; 2015 May; 90(1):17-29. PubMed ID: 26118299
[TBL] [Abstract][Full Text] [Related]
32. Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth.
Zolochevska O; Yu G; Gimble JM; Figueiredo ML
Stem Cells Dev; 2012 May; 21(7):1112-23. PubMed ID: 21671747
[TBL] [Abstract][Full Text] [Related]
33. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma.
Huang D; Ding Y; Li Y; Luo WM; Zhang ZF; Snider J; Vandenbeldt K; Qian CN; Teh BT
Cancer Res; 2010 Feb; 70(3):1053-62. PubMed ID: 20103629
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition.
Fischl AS; Wang X; Falcon BL; Almonte-Baldonado R; Bodenmiller D; Evans G; Stewart J; Wilson T; Hipskind P; Manro J; Uhlik MT; Chintharlapalli S; Gerald D; Alsop DC; Benjamin LE; Bhatt RS
Mol Cancer Ther; 2019 Apr; 18(4):856-867. PubMed ID: 30787172
[TBL] [Abstract][Full Text] [Related]
35. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
Eikesdal HP; Sugimoto H; Birrane G; Maeshima Y; Cooke VG; Kieran M; Kalluri R
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15040-5. PubMed ID: 18818312
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity.
Deshpande M; Notari L; Subramanian P; Notario V; Becerra SP
Int J Oncol; 2012 Jul; 41(1):219-27. PubMed ID: 22504705
[TBL] [Abstract][Full Text] [Related]
37. PEDF and the serpins: phylogeny, sequence conservation, and functional domains.
Tombran-Tink J; Aparicio S; Xu X; Tink AR; Lara N; Sawant S; Barnstable CJ; Zhang SS
J Struct Biol; 2005 Aug; 151(2):130-50. PubMed ID: 16040252
[TBL] [Abstract][Full Text] [Related]
38. Acidic/neutral amino acid residues substitution in NH2 terminal of plasminogen kringle 5 exerts enhanced effects on corneal neovascularization.
Li C; Li L; Cheng R; Dai Z; Li C; Yao Y; Zhou T; Yang Z; Gao G; Yang X
Cornea; 2013 May; 32(5):680-8. PubMed ID: 23343948
[TBL] [Abstract][Full Text] [Related]
39. PEDF inhibits growth of retinoblastoma by anti-angiogenic activity.
Yang H; Cheng R; Liu G; Zhong Q; Li C; Cai W; Yang Z; Ma J; Yang X; Gao G
Cancer Sci; 2009 Dec; 100(12):2419-25. PubMed ID: 19832843
[TBL] [Abstract][Full Text] [Related]
40. [Pigment epithelium-derived factor gene therapy inhibits the growth of transplanted human hepatocellular carcinoma in nude mice].
GAO Y; ZHANG W; ZHAO L; WANG XH
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):363-7. PubMed ID: 19497203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
